# Effect of Chronic ACE and DPP4 Inhibition on Blood Pressure

> **NCT02130687** · NA · COMPLETED · sponsor: **Vanderbilt University** · enrollment: 106 (actual)

## Conditions studied

- Type 2 Diabetes Mellitus
- Hypertension

## Interventions

- **DRUG:** Placebo
- **DRUG:** Sitagliptin
- **DRUG:** Aprepitant
- **OTHER:** Mixed Meal Test (MMT)

## Key facts

- **NCT ID:** NCT02130687
- **Lead sponsor:** Vanderbilt University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2020-05
- **Final completion:** 2020-08
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2022-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02130687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02130687, "Effect of Chronic ACE and DPP4 Inhibition on Blood Pressure". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02130687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*